Skip to Content
  • Previous Rank-
  • Revenue 3 Yr Annual Growth Rate32%
  • Revenue 3 Yr Growth Rank44
  • EPS 3 Yr Annual Growth Rate25%
  • EPS 3 Yr Growth Rank87
  • Total Return 3 Yr Annual Rate39%
  • Total Return 3 Yr Rank25
Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Information

Industry
Medical Products & Equipment
Sector
Health Care
Current Streak-
Years on List1
CEO
Adam Elsesser
Websitehttps://www.penumbrainc.com
Country
U.S.
Headquarters
Alameda, Calif.
Ticker
PEN
Revenue and net income for the four quarters ended on or before April 30, 2019. Total return for the period ended June 28, 2019.

Revenue, Net Income

Revenue past four quarters ($M)$471
Net Income past four quarters ($M)$12
Market Value as of June 28, 2019 ($M)$5,558

Growth Rates and Ranks

Revenue 3 Yr Growth Rank44
Revenue 3 Yr Annual Growth Rate32%
EPS 3 Yr Growth Rank87
EPS 3 Yr Annual Growth Rate25%
Total Return 3 Yr Rank25
Total Return 3 Yr Annual Rate39%
Beat S&P 500 3 Yr Return (14.2%)
yes